DE69937576D1 - Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung - Google Patents

Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung

Info

Publication number
DE69937576D1
DE69937576D1 DE69937576T DE69937576T DE69937576D1 DE 69937576 D1 DE69937576 D1 DE 69937576D1 DE 69937576 T DE69937576 T DE 69937576T DE 69937576 T DE69937576 T DE 69937576T DE 69937576 D1 DE69937576 D1 DE 69937576D1
Authority
DE
Germany
Prior art keywords
bioabcanable
geling
molecular
low
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937576T
Other languages
English (en)
Other versions
DE69937576T2 (de
Inventor
Ramesh C Rathi
Gaylen M Zentner
Byeongmoon Jeong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Inc
Original Assignee
Protherics Salt Lake City Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/396,589 external-priority patent/US6201072B1/en
Application filed by Protherics Salt Lake City Inc filed Critical Protherics Salt Lake City Inc
Publication of DE69937576D1 publication Critical patent/DE69937576D1/de
Application granted granted Critical
Publication of DE69937576T2 publication Critical patent/DE69937576T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66Polyesters containing oxygen in the form of ether groups
    • C08G63/664Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02Polyalkylene oxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
DE69937576T 1998-10-01 1999-09-30 Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung Expired - Lifetime DE69937576T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/164,865 US6117949A (en) 1998-10-01 1998-10-01 Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US164865 1998-10-01
US396589 1999-09-15
US09/396,589 US6201072B1 (en) 1997-10-03 1999-09-15 Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
PCT/US1999/022755 WO2000018821A1 (en) 1998-10-01 1999-09-30 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties

Publications (2)

Publication Number Publication Date
DE69937576D1 true DE69937576D1 (de) 2007-12-27
DE69937576T2 DE69937576T2 (de) 2008-09-18

Family

ID=22596415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937576T Expired - Lifetime DE69937576T2 (de) 1998-10-01 1999-09-30 Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung

Country Status (5)

Country Link
US (1) US6117949A (de)
AR (1) AR022105A1 (de)
DE (1) DE69937576T2 (de)
PT (1) PT1141079E (de)
ZA (1) ZA200102453B (de)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US7087244B2 (en) * 2000-09-28 2006-08-08 Battelle Memorial Institute Thermogelling oligopeptide polymers
US20040228794A1 (en) * 1998-04-10 2004-11-18 Battelle Memorial Institute Therapeutic agent carrier compositions
US6841617B2 (en) * 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
DE60003803T2 (de) 1999-04-16 2004-06-03 Novo Nordisk A/S Trockene formbare arzneistoffformulierung
US6287588B1 (en) * 1999-04-29 2001-09-11 Macromed, Inc. Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
US20040009229A1 (en) * 2000-01-05 2004-01-15 Unger Evan Charles Stabilized nanoparticle formulations of camptotheca derivatives
US7018645B1 (en) * 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
AU2001264623A1 (en) * 2000-05-16 2001-11-26 Biocure, Inc. Membranes formed from amphiphilic copolymers
US7767197B2 (en) 2000-06-22 2010-08-03 Endo Pharmaceuticals Colorado LLC Delivery vehicle composition and methods for delivering antigens and other drugs
ATE355813T1 (de) * 2000-07-14 2007-03-15 Novo Nordisk As Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
AU3104102A (en) * 2000-12-18 2002-07-01 Univ Texas Local regional chemotherapy and radiotherapy using in situ hydrogel
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20040185101A1 (en) * 2001-03-27 2004-09-23 Macromed, Incorporated. Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
ES2286244T3 (es) * 2001-04-20 2007-12-01 The University Of British Columbia Sistemas de suministro de farmaco micelar para farmacos hirofobicos.
KR100488002B1 (ko) * 2001-06-20 2005-05-09 주식회사 삼양사 수용성 폴리알킬렌글리콜로 이루어진 친수성 블록과,방향족 기 함유 α-하이드록시산 유도체와 락타이드의불규칙 공중합체인 소수성 블록으로 이루어진 양친성 블록공중합체
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
KR20030024103A (ko) * 2001-09-17 2003-03-26 육순홍 상전이 현상을 이용한 약물전달용 생분해성 고분자미소구의 제조방법
US6592899B2 (en) 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
AU2002343681B2 (en) * 2001-11-12 2006-07-06 Alkermes Controlled Therapeutics, Inc. Biocompatible polymer blends and uses thereof
CA2467275C (en) * 2001-11-15 2012-09-11 Biomatera Inc. Method for preparing gels
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
EP1997829A1 (de) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin Fusionsproteine
WO2003080629A2 (en) 2002-02-25 2003-10-02 Guilford Pharmaceuticals, Inc. Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US20030228366A1 (en) * 2002-06-11 2003-12-11 Chung Shih Reconstitutable compositions of biodegradable block copolymers
US7037983B2 (en) 2002-06-14 2006-05-02 Kimberly-Clark Worldwide, Inc. Methods of making functional biodegradable polymers
US20030232088A1 (en) * 2002-06-14 2003-12-18 Kimberly-Clark Worldwide, Inc. Materials with both bioadhesive and biodegradable components
US7160551B2 (en) * 2002-07-09 2007-01-09 The Board Of Trustees Of The University Of Illinois Injectable system for controlled drug delivery
JP2006514923A (ja) * 2002-10-25 2006-05-18 ファイザー・プロダクツ・インク 注射可能な新規なデポ製剤
CA2505861A1 (en) * 2002-11-12 2004-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally
US6992543B2 (en) * 2002-11-22 2006-01-31 Raytheon Company Mems-tuned high power, high efficiency, wide bandwidth power amplifier
CN1771041A (zh) * 2003-03-21 2006-05-10 尼克美制药控股有限公司 治疗***功能障碍的***素组合物
CA2519691A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Angiogenesis promotion by prostaglandin compositions and methods
WO2004103342A2 (en) * 2003-05-16 2004-12-02 Alkermes Controlled Therapeutics, Inc. Injectable sustained release compositions
US20040247624A1 (en) * 2003-06-05 2004-12-09 Unger Evan Charles Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
US7179867B2 (en) * 2003-11-26 2007-02-20 Industrial Technology Research Institute Thermosensitive biodegradable copolymer
GB2408510B (en) * 2003-11-28 2008-05-14 Ind Tech Res Inst Thermosensitive biodegradable copolymer
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
EP1711124A4 (de) * 2004-01-12 2011-06-01 Univ Pennsylvania Langzeitabgabe von formulierungen und anwendungsverfahren dafür
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US20060039985A1 (en) * 2004-04-27 2006-02-23 Bennett David B Methotrexate compositions
US20050245905A1 (en) * 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
US20060034889A1 (en) 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
KR20070122519A (ko) * 2005-03-31 2007-12-31 에이피 파마, 인코포레이티드 Peg-폴리아세탈 이블록 및 삼블록 공중합체 및 약학조성물
CN101426529A (zh) * 2005-03-31 2009-05-06 阿帕医药有限公司 Peg-聚(原酸酯)接枝共聚物和药物组合物
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
CN101287507B (zh) * 2005-08-12 2012-12-05 刘江 用于淋巴靶向的方法和装置
US7669732B2 (en) * 2005-10-25 2010-03-02 Imi Cornelius Inc. Cup lid dispenser
CA2629300C (en) 2005-11-17 2014-07-08 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
CN100418528C (zh) * 2006-02-28 2008-09-17 上海华拓医药科技发展有限公司 一种含苦参碱类生物碱的热敏凝胶剂及其制备方法
US7740877B2 (en) 2006-04-07 2010-06-22 University Of Utah Research Foundation Aliphatically modified biodegradable block copolymers as thermogelling polymers
US20100119529A1 (en) * 2006-05-12 2010-05-13 Furgeson Darin Y Elastin-like polymer delivery vehicles
US20080138397A1 (en) * 2006-10-24 2008-06-12 Aradigm Corporation Processes for taste-masking of inhaled formulations
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
EP2091514B1 (de) * 2006-11-09 2013-06-05 Alcon Research, Ltd. Wasserunlösliche polymermatrix zur verabreichung von medikamenten
US20080140106A1 (en) * 2006-12-12 2008-06-12 Kimberly-Clark Worldwide, Inc. Enhanced cuff sealing for endotracheal tubes
CN100535033C (zh) * 2007-02-13 2009-09-02 四川大学 一种聚乳酸嵌段共聚物及其制备方法
WO2008134828A2 (en) 2007-05-04 2008-11-13 Katholieke Universiteit Leuven Tissue degeneration protection
US8642062B2 (en) 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
TWI388591B (zh) * 2008-03-28 2013-03-11 Ind Tech Res Inst 溫度敏感性材料
US8916188B2 (en) * 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
KR20190026056A (ko) 2008-04-21 2019-03-12 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
EP3000462A1 (de) 2008-04-28 2016-03-30 Zogenix, Inc. Neuartige formulierungen zur behandlung von migräne
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
CN102026599A (zh) 2008-05-12 2011-04-20 犹他大学研究基金会 眼内药物递送装置及相关方法
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
KR101477329B1 (ko) 2008-05-14 2014-12-29 오토노미, 인코포레이티드 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
US8652506B2 (en) * 2008-06-05 2014-02-18 Boston Scientific Scimed, Inc. Bio-degradable block co-polymers for controlled release
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CN102105133B (zh) 2008-07-21 2015-06-17 奥德纳米有限公司 控制释放型耳结构调节和先天性免疫***调节组合物以及治疗耳部病症的方法
US20100081622A1 (en) * 2008-09-29 2010-04-01 Sanos Bioscience A/S Reduction of parathyroid hormone levels
TWI374903B (en) 2008-12-31 2012-10-21 Ind Tech Res Inst Biodegradable copolymer hydrogel materials
WO2010132605A1 (en) * 2009-05-13 2010-11-18 Protein Delivery Solutions, Llc Pharmaceutical system for trans-membrane delivery
US8992601B2 (en) 2009-05-20 2015-03-31 480 Biomedical, Inc. Medical implants
AU2010249558A1 (en) 2009-05-20 2011-12-08 Arsenal Medical, Inc. Medical implant
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
US9309347B2 (en) 2009-05-20 2016-04-12 Biomedical, Inc. Bioresorbable thermoset polyester/urethane elastomers
US20110319987A1 (en) * 2009-05-20 2011-12-29 Arsenal Medical Medical implant
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US9155722B2 (en) * 2009-09-18 2015-10-13 Protherics Salt Lake City, Inc. Reconstitutable reverse thermal gelling polymers
KR101838303B1 (ko) * 2009-09-18 2018-03-13 비티지 인터내셔널 리미티드 재구성가능한 가역적 열 겔화 고분자
MX343980B (es) 2009-09-18 2016-12-01 Protherics Medicines Dev Ltd * Copolimeros en tribloque bab que tienen características de liberación mejorada.
US8753621B2 (en) * 2009-09-18 2014-06-17 Protherics Salt Lake City, Inc. BAB triblock polymers having improved release characteristics
EP2490722A4 (de) 2009-10-21 2014-03-05 Otonomy Inc Modulation der geltemperatur poloxamerhaltiger formulierungen
EP2343046A1 (de) 2010-01-08 2011-07-13 Nirvana's Tree House B.V. Funktionalisierte Triblockcopolymere und Zusammensetzungen, die solche Polymere enthalten
GB2480295A (en) * 2010-05-12 2011-11-16 Alan John Waddon Polymeric aqueous composition
CA2719855A1 (en) * 2010-11-02 2012-05-02 University Health Network Temperature sensitive hydrogel and block copolymers
US20140066439A1 (en) 2010-11-10 2014-03-06 Katholieke Universiteit Leuen, K.U.Leuven R&D Osteoclast activity
KR101966369B1 (ko) * 2010-12-17 2019-04-08 에스케이케미칼 주식회사 폴리유산 수지 조성물 및 포장용 필름
KR101286854B1 (ko) * 2011-09-29 2013-07-17 중앙대학교 산학협력단 폴리락트산(a)과 폴리에틸렌글리콜(b)로 이루어진 bab형 삼중 블록 공중합체, 이의 제조방법 및 이를 이용한 약물전달체
GB201117296D0 (en) * 2011-10-07 2011-11-16 Neotherix Ltd Sampling device
CA2861258C (en) * 2012-02-08 2019-08-20 Toray Industries, Inc. Stimuli-responsive material and medical material comprising same
RU2508094C1 (ru) * 2012-08-03 2014-02-27 Андрей Юрьевич Хоменко Способы получения трансдермальных терапевтических систем на основе сополимеров молочной и гликолевой кислот (варианты)
US20140271903A1 (en) * 2013-03-14 2014-09-18 Northeast Ohio Medical University Use of thermo-sensitive gel for controlled delivery of alk-5 inhibitors to the eye and related methods
EP2992008B1 (de) 2013-05-02 2019-04-10 GlaxoSmithKline Intellectual Property Development Limited Therapeutische peptide
CA2921816A1 (en) 2013-08-27 2015-03-05 Otonomy, Inc. Treatment of pediatric otic disorders
EP2842583A1 (de) 2013-08-29 2015-03-04 Ella-CS, s.r.o. Biologisch abbaubare und biologisch erodierbare Polyurethane, Verfahren zu ihrer Herstellung und Verwendung
AU2015284048A1 (en) 2014-07-03 2017-02-16 Otonomy, Inc. Sterilization of ciprofloxacin composition
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
PT3302431T (pt) 2015-06-04 2020-11-30 Crititech Inc Partículas de taxano e a sua utilização
US20170029511A1 (en) 2015-07-28 2017-02-02 Otonomy, Inc. Trkb or trkc agonist compositions and methods for the treatment of otic conditions
RU2018113280A (ru) 2015-09-16 2019-10-16 ДиЭфБи СОРИА, ЭлЭлСи Доставка наночастиц лекарственного средства и способы их использования
US11246863B2 (en) 2015-12-11 2022-02-15 Alk-Abelló, Inc. Ciprofloxacin otic composition and kits and method for using same
JP6970683B2 (ja) 2016-04-04 2021-11-24 クリティテック・インコーポレイテッド 固形腫瘍治療のための方法
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
CN110636833B (zh) 2017-03-15 2024-07-09 Dfb索里亚有限责任公司 使用紫杉烷纳米颗粒治疗皮肤恶性肿瘤的局部疗法
EP3375452A1 (de) 2017-03-16 2018-09-19 Evangelos Andreakos Verwendung von lambda-interferonen bei der behandlung von störungen und verwandten erkrankungen
WO2018175268A1 (en) * 2017-03-19 2018-09-27 Biohealthways, Inc. Biodegrading implantable ocular sustained release drug delivery system
JP2020523285A (ja) 2017-06-09 2020-08-06 クリチテック,インコーポレイテッド 抗腫瘍粒子の嚢胞内注入による上皮嚢胞の治療
KR102303762B1 (ko) 2017-06-14 2021-09-23 크리티테크, 인크. 폐 장애의 치료 방법
CA3076919A1 (en) 2017-10-03 2019-04-11 Crititech, Inc. Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
EP3692089A1 (de) * 2017-10-04 2020-08-12 Fashion Chemicals, GmbH & Co. KG Neuartige polymilchsäureester und zusammensetzungen davon
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss
CN112165949A (zh) 2018-03-16 2021-01-01 Dfb索里亚有限责任公司 使用紫杉烷纳米颗粒治疗宫颈上皮内瘤变(cin)和***的局部疗法
WO2020254249A1 (en) 2019-06-21 2020-12-24 Proqr Therapeutics Ii B.V. Delivery of nucleic acids for the treatment of auditory disorders
JP2022547532A (ja) * 2019-09-09 2022-11-14 パシラ・セラピューティクス・インコーポレイテッド ナトリウムチャネルブロッカーを含む徐放性熱硬化性ゲルおよびそれを製造する方法
CN112354018A (zh) * 2020-11-03 2021-02-12 南京思元医疗技术有限公司 一种用于医疗美容的软组织填充水凝胶及其制备方法
EP4014963A1 (de) * 2020-12-16 2022-06-22 Medincell Pharmazeutische zusammensetzung
CN113354800A (zh) * 2021-06-22 2021-09-07 山东谷雨春生物科技有限公司 一种peg嵌段聚乙丙交酯及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378250D1 (en) * 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
EP0258780B1 (de) * 1986-09-05 1993-06-23 American Cyanamid Company Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
JPH064540B2 (ja) * 1988-09-14 1994-01-19 多木化学株式会社 医用組成物
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers

Also Published As

Publication number Publication date
PT1141079E (pt) 2008-02-04
DE69937576T2 (de) 2008-09-18
US6117949A (en) 2000-09-12
AR022105A1 (es) 2002-09-04
ZA200102453B (en) 2001-09-28

Similar Documents

Publication Publication Date Title
DE69937576D1 (de) Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung
ATE290037T1 (de) Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung
DE69933575D1 (de) Wärmeschrumpfbare barrierefilme
ZA989009B (en) Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
DE69720614D1 (de) Verschlüsselungseinheit mit Kontaktpunktlogik
DE69738180D1 (de) Photochrome naphthopyran-zusammensetzungen mit verbesserter ermüdungsbeständigkeit
DE69719701D1 (de) Wärmesperrschichtsysteme und -materialien
DE69813044D1 (de) Blockcopolymer, Blockcopolymerzusammensetzung und ihr hitzeschrumpfbare Folien
DE60123772D1 (de) Mischungen von triblockcopolymeren von polyester-polyethylenglycol
DE69812787D1 (de) Nass in Nass-Grundierung mit UV-Schutz und niedriger Filmbildungstemperatur
DE69833280D1 (de) Saugfähige Bahnen mit zwei Zonen
DE69905628D1 (de) Thermoplastische Polymerzusammensetzung
ID29222A (id) Polimer-polimer siloksan fotokurabel
DE69823179D1 (de) Superabsorbierende polymere mit verbesserter verarbeitbarkeit
DE69830352D1 (de) Thermoplastische Polymerzusammensetzung
KR960010755A (ko) 내충격성이 개선된 폴리과 충격조절제 혼합물
DE60034380D1 (de) Wärmeschrumpfbarer Polyesterfilm
DE69735381D1 (de) Polymerischer tauchheizkörper mit skelettartiger stutzelement
DE69717213D1 (de) Wärmeschrumpfbare Polyesterfolien
DE60022427D1 (de) Wärmeschrumpfbare Polyesterfolie
DE69724070D1 (de) Spiralmaschine mit Gegendrehrichtungsschutz
DE69516101D1 (de) Vernetzte Polymere
DE60021671D1 (de) Wärmeschrumpfbare Polyesterfolien
DE69931695D1 (de) Geldautomat mit front- und heck-beschickbaren Konfigurationen
FR2770213B1 (fr) Revetements de circulation ou elements connexes reflechissants, et composition correspondante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition